Advances in Hemophilia A: Expert Guidance and Practical Case Discussions

Gain insights into the latest advances in treatment of hemophilia A, including nonfactor and gene therapies, through expert-guided discussion and case-based examples.
Michael Callaghan, MD
Stacy Croteau Headshot
Stacy E. Croteau, MD, MMS
person default
Cindy A. Leissinger, MD
Guy A. Young, MD

Downloadable Slidesets

Learn the current clinical progress and unmet needs in hemophilia A treatment.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Review of the current and emerging factors including extended half-life factors, immunogenicity, and how to use pharmacokinetics to individualize therapy.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Learn about emicizumab and its impact on monitoring assays and surgical management in hemophilia A.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Learn the rationale and efficacy and safety data for emerging extended half-life factor replacement and nonfactor replacement strategies for hemophilia A, including mimetics, rebalancers, and gene therapy.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019

Explore practical issues in hemophilia A, including managing breakthrough bleeds, surgery, immune tolerance induction, and previously untreated patients.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: December 5, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue